(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...
Dr. Mehmet Oz, the former surgeon and television host, was nominated to head the Centers for Medicare and Medicaid Services.
The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
"Skyrocketing drug prices are hammering patients in Vermont and across America," Welch said in a statement. "Lifesaving drugs that help treat cancers, blood clots, asthma and multiple sclerosis ...